Skip to content
Research Article Open access CC BY 4.0

An Improved Commercially Feasible Process for Flecainide Acetate

Nilesh Takale, Neelakandan Kaliyaperumal, Gopalakrishnan Mannathusamy, Rajarajan Govindasamy

Journal of Pharmaceutical Research International · pp. 421–430 · Published 15 Oct 2021

10.9734/jpri/2021/v33i46A32885

Abstract

Commercially viable manufacturing process for Flecainide Acetate (I) conforming to regulatory specification and cost effective process is reported. Specifically, an improved process for the preparation of Flecainide Acetate allows isolation of anhydrous hydrochloride salt of Compound III, which facilitates the reduction of the pyridine ring with the only catalytic amount of platinum on carbon within 2 hours Therefore, simplifies the synthesis and isolation of Flecainide acetate on a commercial scale to a considerable extent.

Cardiac depressant catalytic hydrogenation platinum catalyst antiarrhythmic boric acid

Cited by 0

No indexed citations yet.

Article metrics

Real usage data collected on this platform.

0

Page views

0

PDF downloads

0

Outbound clicks

0

Citations

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

No views recorded yet.

Traffic sources

Referring site, by host.

No traffic recorded yet.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.